Your session is about to expire
← Back to Search
Laser Surgery
Wave-Front Optimized (WFO) ablation vs Topography-guided (TG) ablation for Refractive Surgery
N/A
Recruiting
Led By CHARISMA B EVANGELISTA, MD
Research Sponsored by 59th Medical Wing
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months post-surgery
Awards & highlights
Study Summary
This trial will compare two different types of surgery to see which one provides better vision.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months post-surgery
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months post-surgery
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Post-operative refractive error
Secondary outcome measures
Post-operative Uncorrected Visual Acuity
Trial Design
2Treatment groups
Experimental Treatment
Group I: PRK refractive surgeryExperimental Treatment1 Intervention
Contralateral Randomize Wave-Front Optimized (WFO) ablation vs Topography-guided ablation
Group II: LASIK refractive surgeryExperimental Treatment1 Intervention
Contralateral Randomize Wave-Front Optimized (WFO) ablation vs Topography-guided ablation
Find a Location
Who is running the clinical trial?
59th Medical WingLead Sponsor
39 Previous Clinical Trials
12,100 Total Patients Enrolled
CHARISMA B EVANGELISTA, MDPrincipal Investigator59th Medical Wing
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are breastfeeding at any point during the study.You have a history of dry eyes.You have a condition called hyperopia (farsightedness).You have had eye surgery or injury in the past or currently have an eye problem.You want treatment for one eye to see up close and the other eye to see far away.
Research Study Groups:
This trial has the following groups:- Group 1: PRK refractive surgery
- Group 2: LASIK refractive surgery
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Does your study require participants to be of a certain age?
"As long as potential patients are aged between 21 and 50, they will meet the age-based eligibility criteria for this trial."
Answered by AI
Are you currently recruiting patients for this research project?
"This study aims to enroll 400 individuals that have had refractive surgery and meet the following age requirement: between 21 and 50 years old. It is also essential that these patients meet the following prerequisites: requirements for PRK or LASIK (i.e., Stable <= .5 D change MRSE), DOD beneficiaries age 21-50 years, Local pts (w/i 60 mi) who will be in the area for at least 6 months post surgery, Willing to complete all required follow-up visits."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger